The Oncology Institute, Inc. STLN
3.62 USD -3.08 (-45.97%)
At closeNov 6, 2026, 7:18 PM EST
3.63 +0.01 +0.28%
After hours · Nov 6, 7:18 PM ET
3.35 Day range 6.43
2.38 52-week range 7.05
- YTD
- +1.69%
- 1 year
- -4.99%
- Market cap
- 368.94M
- EPS (ttm)
- -0.29
- YTD return
- +1.69%
- 1-year return
- -4.99%
- Volume
- 23.92M
- Avg volume
- 1.38M
- Open
- 6.06
- Previous close
- 6.70
- Day's range
- 3.35 – 6.43
- 52-week range
- 2.38 – 7.05
5D -2.90 (-44.48%)
Financials — quick view
STLN Revenue — quarterly 161.28M
STLN Net income — quarterly -8.24M
STLN EPS — quarterly -0.08
News
B. Riley Securities Reiterates Buy on Starling Oncology, Lowers Price Target to $10 
Oncology Institute Q3 Earnings Call Highlights 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
BTIG Maintains Buy on Starling Oncology, Raises Price Target to $10 
Starling Oncology Q3 2026 Earnings Call Transcript - Starling Oncology Narrows FY2026 Sales Guidance from $650.000M-$670.000M to $650.000M-$660.000M vs $663.685M Est
Starling Oncology Q3 EPS $(0.13) Misses $(0.05) Estimate, Sales $169.767M Beat $169.047M Estimate - Needham Maintains Buy on Starling Oncology, Raises Price Target to $9
12 Health Care Stocks Moving In Friday's After-Market Session - Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
Your note
Sign in to keep a note on STLN — it syncs with the Stock Master app.